A patient orders a panel online because she has been tired for months. Three days later a number arrives in an email, flagged outside a range, with no explanation and nobody to ask.
She spends the weekend reading forums and arrives at her own clinician on Monday considerably more frightened than when she started.
The decision a laboratory is making
Not whether people want this. They do. Whether to provide a number or provide an answer, and those are different services with different obligations.
When a direct model works well
Defined wellness panels, monitoring where a clinician is already involved, straightforward tests with clear interpretation, and any arrangement where a clinician reviews results before release.
When it does not
Anybody describing symptoms, anybody with a diagnosed condition, tests whose results need context, and anything where an abnormal result would need immediate action.
Decide whether a clinician is involved
Before ordering, after results, or not at all. It is the single decision that determines what kind of service this is, and it should be visible to the patient.
Publish what each panel is for
In plain words, with what it does and does not indicate. Patients choose by name and have no way of judging what they are buying, which is the arithmetic in the panel comparison work most laboratories never publish.
Publish what happens with an abnormal result
Who contacts the patient, how quickly, whether a clinician reviews it and what the patient should do. This is the whole safety question and it belongs before the order.
Never interpret a result in an enquiry
Nothing automated or administrative should comment on a number. Published information about what a panel covers is fine. Anything about a person's own result is not.
Publish the limits plainly
That this is not a substitute for seeing a clinician, that some things cannot be detected this way and when somebody should see a doctor instead. Saying it prominently is what makes the service responsible.
Explain the preparation requirements
Fasting, timing, medication and anything that affects the result. Direct patients have nobody to tell them and get it wrong.
Explain how the sample is taken
Attendance, a clinic, a home visit or a kit, with what each involves, which is the ground in GP and clinic referral questions for private testing.
Explain what the patient receives
A number, a range, a report or an explanation. And whether they can take it to their own clinician, which is what most of them will do.
Explain the cost completely
Test, sample collection, any clinician review and any follow up. Direct patients compare on price and discover additions.
Keep the clinician channel separate
Referring practices need an entirely different page and a different process, as in referral and requisition questions from clinicians.
Answer the enquiry quickly
Direct patients are anxious and go to whoever responds, which is the advantage described in private clinics competing on response speed, tested against real questions as in testing an assistant with real past enquiries.
Getting started
Decide and publish your clinician involvement, what each panel indicates and what happens with an abnormal result, then answer at any hour without interpreting anything. SpideyChat for healthcare organisations answers from your published pages, plans are on the pricing page, and the chatbot ROI calculator works through the numbers.